Rankings
▼
Calendar
IART Q2 2016 Earnings — Integra LifeSciences Holdings Corporation Revenue & Financial Results | Market Cap Arena
IART
Integra LifeSciences Holdings Corporation
$749M
Q2 2016 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$249M
Gross Profit
$160M
64.1% margin
Operating Income
$22M
9.0% margin
Net Income
$13M
5.1% margin
EPS (Diluted)
$0.16
QoQ Revenue Growth
+5.3%
Cash Flow
Operating Cash Flow
$44M
Free Cash Flow
$36M
Stock-Based Comp.
$5M
Balance Sheet
Total Assets
$1.8B
Total Liabilities
$1.0B
Stockholders' Equity
$795M
Cash & Equivalents
$87M
Revenue Segments
Specialty Surgical Solutions
$158M
63%
Orthopedics and Tissue Technologies
$91M
37%
Geographic Segments
UNITED STATES
$192M
77%
Europe
$32M
13%
Rest Of World
$26M
10%
← FY 2016
All Quarters
Q3 2016 →
